| |
| therapy |
Epidural
spinal cord stimulation for interstitial cystitis [Article in Spanish]
Pelaez E, Prieto Rodrigo
MA, Munoz Zurdo MM, et al. Rev Esp Anestesiol Reanim 2004;51:549-52 |
|
| |
Die
stationäre urologische Rehabilitation bei interstitieller
Cystitis.
W. Vahlensieck. Der Urologe A (Issue: Online
First) [Article in German]
• this paper describes results of a multidisciplinary approach to the urgency,
frequency, nocturia and pain in IC patients. |
|
| |
Modified
Thiele massage as therapeutic intervention for female patients
with interstitial cystitis and high-tone pelvic floor dysfunction.
Oyama IA, Rejba A, Lukban JC, et
al. Urology 2004;64:862-8 |
|
| |
Botulinum
toxin A has antinociceptive effects in treating interstitial
cystitis.
Smith CP, Radziszewski P, Borkowski A, et
al. Urology 2004;64:871-5 |
|
| |
Transdermal
posterior tibial nerve laser therapy is not effective in
women with interstitial cystitis.
O'Reilly BA, Dwyer PL, Hawthorne G, et
al. J Urol 2004;172:1880-3 |
|
| |
A
pilot clinical trial of oral pentosan polysulfate and oral
hydroxyzine in patients with interstitial cystitis
Sant GR, Propert KJ, Hanno PM, et al.
J Urol 2003;170:810-5. |
|
| |
Treatment
of interstitial cystitis.
Chancellor MB, Yoshimura N.
Urology 2004;63(suppl 1):85-92 |
|
| |
Initial,
long-term, and durable responses to terazosin, placebo, or
other therapies for chronic prostatitis/chronic pelvic pain
syndrome.
Cheah PY, Liong ML, Yuen KH, et al. Urology 2004;64:881-6 |
|
| |
Patient-adjusted
intermittent electrostimulation for treating stress and urge
urinary incontinence.
Nissenkorn I, Shalev M, Radziszewski
P, et al. BJU Int 2004;94:105-9 |
|
| |
Urinary
urgency and frequency, and chronic urethral and/or pelvic pain
females. Can doxycycline help?
Burkhard FC, Blick N, Hochreiter WW, et
al. J Urol 2004;172:232-5 |
|
| |
A
prospective, randomized, placebo controlled, double-blind study
of amitriptyline for the treatment of interstitial cystitis.
van Ophoven A, Pokupic S, Heinecke A, et
al. J Urol 2004;172:533-6 |
|
| |
Posterior
tibial nerve stimulation in patients with intractable interstitial
cystitis.
Zhao J, Nordling J. BJU Int 2004;94:101-4.
• intermittent percutaneous posterior tibial
nerve stimulation in patients with refractory interstitial
cystitis has no significant clinical effect over 10
weeks of treatment. |
|
| |
Long-term
outcome of patients with interstitial cystitis treated with
low dose cyclosporine A.
Sairanen J, Forsell T, Ruutu
M. J Urol 2004;171:2138-41.
• the initial cyclosporine dose: 3 mg/kg divided into 2 daily dosages; this
was an open trial, a randomized trial is now being performed |
|
| |
Patient-adjusted
intermittent electrostimulation for treating stress and urge
urinary incontinence.
Nissenkorn I, Shalev M, Radziszewski
P, et al. BJU Int 2004;94:105-9 |
|
| |
Sacral
neuromodulation for the treatment of refractory interstitial
cystitis: outcomes based on technique.
Peters KM, Carey JM, Konstandt DB. Int
Urogynecol J Pelvic Floor Dysfunct 2003;14:223-8 |
|
| |
The
use of electrical devices for the treatment of bladder dysfunction:
a review of methods.
van Balken MR, Vergunst H, Bemelmans BL. J Urol
2004;172:846-51 |
|
| |
Caecocystoplasty
for intractable interstitial cystitis: long-term results.
Chakravarti A, Ganta S, Somani B, et
al. Eur Urol 2004;46:114-7 |
|
| |
Hyperbaric
oxygen for the treatment of interstitial cystitis: long-term
results of a prospective pilot study.
van Ophoven A, Rossbach G, Oberpenning
F, et al. Eur Urol 2004;46:108-13 |
|
| |
Hypersensitivity
reaction associated with intravesical Bacillus Calmette-Guerin
for interstitial cystitis.
Parker C, Steele S, Raghavan R, et al. J Urol 2004;172:537 |
|
| |
Sacral
neuromodulation decreases narcotic requirements in refractory
interstitial cystitis.
Peters KM, Konstandt D. BJU Int 2004;93:777-9 |
|
| |
Current
strategies for managing interstitial cystitis.
Parsons CL. Expert Opin Pharmacother
2004;5:287-93 |
|
| |
Assessing
self-help issues for patients with prostate cancer, interstitial
cystitis, erectile dysfunction and urinary diversion.
Breau RH, McGrath PJ, Norman RW. BJU
Int 2003;92:736-40 |
|
| |
|
|
| symptoms |
Different
clinical presentation of interstitial cystitis syndrome.
Porru D, Politano R, Gerardini M, et
al. Int Urogynecol J Pelvic Floor Dysfunct 2004;15:198-202. |
|
| |
|
|
| diagnosis |
Future
research needs for the definition/diagnosis of interstitial
cystitis.
Bade J, Ishizuka O, Yoshida M. Int J Urol
2003;10(suppl):S31-4 |
|
| |
Interstitial
cystitis: modern tools for an accurate diagnosis.
Nipkow L, Chai TC. Curr Urol Rep 2003;4:381-4 |
|
| |
Intravesical
potassium chloride sensitivity test in men with chronic pelvic
pain syndrome.
Yilmaz U, Liu YW, Rothman I, et al. J Urol 2004;172:548-50 |
|
| |
Interstitial
cystitis. New aspects in diagnosis and therapy.
[article in German] Loch A, Stein U.
Urologe A. 2004;43:1135-46 |
|
| |
A
referral center's experience with transitional cell carcinoma
misdiagnosed as interstitial cystitis.
Tissot WD, Diokno AC, Peters KM. J
Urol 2004;172:478-80
|
|
| |
Primary
evaluation of patients suspected of having interstitial cystitis
(IC).
Nordling J, Anjum FH, Bade JJ, et
al. Eur Urol 2004;45:662-9. |
summary
pdf |
| |
Interstitial
cystitis: how should we diagnose it and treat it in 2004 ?
Nordling J. Curr Opin Urol 2004;14:323-7 |
|
| |
|
|
| aetiology
& pathogenesis |
Interstitial
cystitis antiproliferative factor (APF) as a cell-cycle modulator.
Rashid HH, Reeder JE, O'Connell MJ, et
al. BMC Urol 2004;4:3 |
|
| |
Possible
mechanisms inducing glomerulations in interstitial cystitis:
relationship between endoscopic findings and expression of
angiogenic growth factors.
Tamaki M, Saito R, Ogawa O, et al. J Urol 2004;172:945-8 |
|
| |
Expression
of intercellular adhesion molecules in the bladder of patients
with interstitial cystitis.
Green M, Filippou A, Sant G, et
al. Urology 2004;63:688-93. |
|
| |
Interstitial
cystitis: a review of immunological aspects of the aetiology
and pathogenesis, with a hypothesis.
van de Merwe JP, Arendsen HJ. BJU Int
2000;85:995-9. |
|
| |
|
|
| other
cystitis |
Eosinophilic
cystitis induced by penicillin.
Tsakiri A, Balslev I, Klarskov P. Int Urol Nephrol
2004;36:159-61
• a 30-year-old woman developed classic symptoms of painful bladder disease
and eosinophilic cystitis as an adverse effect of penicillin for abdominal actinomycosis.
The symptoms were reversible after stopping penicillin. |
|
| |
Eosinophilic
cystitis after bladder instillation with dimethyl sulfoxide.
Abramov Y, Goldberg RP, McGuire M, et
al. Urology 2004;63:1182-3 |
|
| |
Is
there an ethnic difference in the prevalence of lupus cystitis?
A report of six cases.
Chen MY, Lee KL, Hsu PN, et al. Lupus 2004;13:263-9 |
|
| |
|
|
| overactive
bladder |
Defining
overactive bladder: epidemiology and burden of disease.
Tubaro A. Urology 2004;64(Suppl
1):2-6 |
|
| |
- The
urothelium in overactive bladder: passive bystander or
active participant?
de Groat WC. Urology 2004;64 (Suppl 1):7-11
|
|
| |
- Urgency:
the cornerstone symptom of overactive bladder.
Brubaker L. Urology 2004;64(Suppl
1):12-6
|
|
| |
- The
patient's perspective: redefining end points.
Palmtag H. Urology 2004;64(Suppl 1):17-20
|
|
| |
- Update
on nocturia: the best of rest is sleep.
Marschall-Kehrel D. Urology 2004;64(Suppl
1):21-4
|
|
| |
Passive
transfer of Sjögren's syndrome IgG produces the pathophysiology
of overactive bladder.
Wang F, Jackson MW, Maughan V, et al. Arthritis Rheum 2004;50:3637-45 |
|
| |
Post-void
residual urine volume in women with overactive bladder symptoms.
Milleman M, Langenstroer P, Guralnick
ML. J Urol 2004;172:1911-4 |
|
| |
|
|
| related
disorders |
A
double-blind, multicenter trial comparing duloxetine with placebo
in the treatment of fibromyalgia patients with or without major
depressive disorder.
Arnold LM, Lu Y, Crofford LJ, et al. Arthritis Rheum 2004;50:2974-84
• in this trial, duloxetine (an antidepressant drug that is also used for
overactive bladder and stress incontinence) was an effective and safe treatment
for many of the symptoms associated with fibromyalgia in subjects with or without
major depressive disorder, particularly for women, who had significant improvement
across most outcome measures. |
|
| |
Interstitial
cystitis, chronic nonbacterial prostatitis and chronic pelvic
pain syndrome in men: a common and frequently identical clinical
entity.
Forrest JB, Schmidt S. J Urol 2004;172:2561-2 |
|
| |
Comorbidity
of interstitial cystitis with other unexplained clinical conditions.
Buffington CA. J Urol 2004;172:1242-8 |
|
| |
Nonbladder
related symptoms in patients with interstitial cystitis.
Erickson DR, Morgan KC, Ordille S, et
al. J
Urol 2001;166:557-61 |
|
| |
Mechanisms
in prostatitis/chronic pelvic pain syndrome.
Pontari MA, Ruggieri MR. Urol 2004;172:839-45 |
|
| |
Physiopathologic
relationship between interstitial cystitis and rheumatic, autoimmune,
and chronic inflammatory diseases. [Article
in Spanish] Lorenzo Gomez MF, Gomez Castro S. Arch Esp Urol
2004;57:25-34 |
|
| |
Systemic
aspects of interstitial cystitis, immunology and linkage
with autoimmune disorders.
van de Merwe JP, Yamada T, Sakamoto
Y. Int J Urol 2003;10 (suppl):S35-8 |
|
| |
|
|
| education |
EAU
Update Series, December 2004 Volume 2, Issue 4, Pages 151-195:
Neurourology
• new understanding of central
and peripheral interaction between bladder and sphincter function
• comparison of peripherally acting substance for treatment of detrusor
overactivity: what is new; what is in the pipeline?
• botox in urology: a new treatment modality without limitations?
• pelvic pain and interstitial cystitis: therapeutic strategies, results
and limitations
• neuromodulation -sacral, peripheral and central: current status, indications,
results and new developments |
|
| |
Case
of the month. Interstitial cystitis.
Smith JL. JAAPA 2004;17:48 |
|
| |
EAU
guidelines on chronic pelvic pain.
Fall M, Baranowski AP, Fowler CJ, et
al. EAU. Eur Urol 2004;46:681-9
• new amended summary. |
|
| |
|
|
| mast
cells |
Protease
activated receptor stimulation activates a calcium-independent
phospholipase A2 in bladder microvascular endothelial cells.
Rickard A, Portell C, Kell PJ, Vinson
SM, McHowat J. Am J Physiol Renal Physiol. 2004; Nov 23; [epub ahead
of print] |
|
| |
An
antiproliferative factor from interstitial cystitis patients
is a frizzled 8 protein-related sialoglycopeptide.
Keay SK, Szekely Z, Conrads TP, et
al. Proc Natl Acad Sci USA 2004;101:11803-8 |
|
| |
Panic
disorder, interstitial cystitis, and mast cells.
Theoharides TC. J Clin Psychopharmacol 2004;24:361-4 |
|
| |
|
|
| markers |
- Is
urine methylhistamine a useful marker for interstitial
cystitis ?
Erickson DR, Kunselman AR, Bentley CM, et
al. J Urol 2004 ;172:2256-60
|
|
| |
- Nitric
oxide as an objective marker for evaluation of treatment
response in patients with classic interstitial cystitis.
Hosseini A, Ehren I, Wiklund NP.
J Urol 2004;172:2261-5
|
|
| |
Antiproliferative
factor, heparin-binding epidermal growth factor-like growth
factor, and epidermal growth factor in men with interstitial
cystitis versus chronic pelvic pain syndrome.
Keay S, Zhang CO, Chai T, et al. Urology 2004;63:22-6 |
|
| |
Interstitial
cystitis antiproliferative factor (APF) as a cell-cycle modulator.
Rashid HH, Reeder JE, O'Connell MJ, et
al. BMC Urol 2004;4:3 |
|
| |
|
|
| prevalence |
Prevalence
of interstitial cystitis in young women.
Parsons CL, Tatsis V. Urology 2004;64:866-70
• the investigators identified probable IC in 30.6%
and documented IC in a minimum of 10% of the female medical
students. |
|
| |
Prevalence
of interstitial cystitis in first-degree relatives of patients
with interstitial cystitis.
Warren JW, Jackson TL, Langenberg P, et
al. Urology 2004;63:17-21 |
|
| |
|
|
| various |
Interstitial
cystitis in persistent posthysterectomy chronic pelvic pain
Chung MK. JSLS 2004;8:329-33 |
|
| |
Is
questionnaire enough to assess number of nocturic episodes
? : Prospective comparative study between data from questionnaire
and frequency-volume charts.
Ku JH, Hong SK, Kim HH, et al. Urology 2004;64:966-9 |
|
| |
Detrusor overactivity, does it represent a difference if patients feel the involuntary contractions?
Wyndaele J-J, van Meel TD, de Wachter S. J Urol 2004;172:1915-8 |
|
